Published date: 13 December 2019

Last edited date: 13 December 2019

This notice was replaced on 23 June 2020

This notice does not contain the most up-to-date information about this procurement. The most recent notice is:

Awarded contract (published 23 June 2020)

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.


Contract summary

Industry

  • Pharmaceutical products - 33600000

  • Various medicinal products - 33690000

Location of contract

North East, North West, Yorkshire and the Humber, East Midlands, West Midlands, East of England, London, South East, South West, Isle of Man, Channel Islands

Value of contract

£27,500,000

Procurement reference

tender_225112/816235

Published date

13 December 2019

Closing date

15 January 2020

Contract start date

4 May 2020

Contract end date

31 January 2022

Contract type

Supply contract

Procedure type

Open procedure (above threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

NHS National Pharmaceuticals Transition 2020_1
Offer reference number: CM/PHG/19/5586
Period of framework agreement: The total maximum duration of the framework agreement to be no more than 42 months
Potential periods of call-offs under the framework agreement:
LSNE: 04/05/2020 to 31/01/2022 (21 months)
CESW: 04/05/2020 to 31/01/2021 (9 months)
NWLN: 04/05/2020 to 31/07/2021 (15 months)

More information

Attachments

Links

About the buyer

Contact name

Lynne Tierney

Address

2nd Floor, Rutland House
Runcorn
WA7 2ES
England

Email

lynne.tierney@nhs.net